Alliance participants agree to use evidence to identify and measure quality health care, then produce publicly-available reports designed to help improve health care decision-making. Reports measuring the quality of care provided in the Puget Sound region, along with useful information and tools, can be helpful in health care decisions, including identifying effective care, choosing or designing health benefit plans, deciding which doctor to see, knowing what questions to ask to get the best quality, and understanding what we each can do to improve our own health.

For more information: http://www.pugetsoundhealthalliance.org .

back to top

back to top

Thrombosis, Warfarin Dosing, Tamoxifen Response, Factor II, Factor V and MTHFR Assays Validated

back to top

Iverson Genetic Diagnostics Announces the Successful Completion of Series A Financing

January 13, 2007 (Seattle, WA)

The next round of financing will propel Iverson to advance research, product development, production, permits, licensing and other overhead costs. Key milestones to achieve during this phase of financing will include the development and product offering of our new recently acquired microarray synthesizer. The capability to custom design probe sequences on an array will allow a medical provider with the necessary tools to screen patients for genetic mutations which are important to their practice. Iverson Genetics will first offer pre-fabricated panel microarrays that will be able to detect the route cause for Upper Respiratory Tract Infections and specific strains of the Influenza virus that may or may not be treatable with the current medication.

For more information here .

back to top

Science Magazine announces "Human Genetic Variation" as the Breakthrough of the Year

December 21, 2007 (Washington, DC)

Bolstered by recent discoveries in the field of genomics, Science Magazine recently reported "Human Genetic Variation" as its Breakthrough of the Year.

Excerpt:
New technologies that are slashing the costs of sequencing and genome analyses will make possible the simultaneous genome-wide search for SNPs and other DNA alterations in individuals. Already, the unexpected variation within one individual's published genome has revealed that we have yet to fully comprehend the degree to which our DNA differs from one person to the next. Such structural and genetic variety is truly the spice of our individuality."

Read the entire article here .

back to top

Welcome to the Age of Genomics. Nov 07 issue of Wired Magazine devoted to the advent of retail genomics

November 17, 2007 ( San Francisco , CA)

back to top

Iverson to attend the East Coast Reception hosted by The Personalized Medicine Coalition - Jan 17th, 2008

December 4, 2007 ( Boston , MA)

Iverson Genetic Diagnostics, Inc will be attending the East Coast Personalized Medicine Coalition taking place January 17, 2008. The Personalized Medicine Coalition (PMC) is an independent, non-profit group that works to advance the understanding and adoption of personalized medicine for the ultimate benefit of patients.

For more information: http://www.personalizedmedicinecoalition.org/

back to top

Iverson joins WBBA

November 12, 2007 (Seattle, WA)

Iverson Genetic Diagnostics, Inc has recently joined membership to the WBBA. The non-profit association is composed of world class biotechnology, biomedical, research, and other related business. The biotechnology companies are involved with performing biological research that leads to the development and manufacturing of medical, environmental, and agricultural products. Biomedical organizations focus on the development and production of diagnostic and electrical tools that can be used by medical researchers and other health care specialists.

Washington State and the greater Seattle metropolitan area have been recognized for being one of the leading biotechnology centers in the world. Membership in the WBBA places Iverson Genetic Diagnostics within the scientific community that is actively developing innovative solutions to preventative diagnostics and treatments of many life-threatening conditions. This industry thrives on a foundation of premier research institutions, the regions rapidly growing financial health, unmatched standard to the quality of life, and remarkable entrepreneurial spirit.

For more information: http://www.wabio.com/

back to top

Iverson registers for the American Association of Clinical Chemistry

November 12, 2007 (Seattle, WA)

AACC is an international scientific/medical society of clinical laboratory professionals, physicians, research scientists and other individuals involved with clinical chemistry and related disciplines. Founded in 1948, the society has 10,000 members and is headquartered in Washington , DC .

AACC advances laboratory medicine through our scientific journal Clinical Chemistry and other publications, our patient-centered web site Lab Tests online, our international Annual Meeting & Clinical Lab Expo, online and in-person conferences, and other programs. AACC offers many programs that address the scientific, clinical, technical, and management challenges facing laboratory professionals.

For more information: http://www.aacc.org

back to top

Iverson becomes a member of the Genetic Alliance

November 10, 2007 (Seattle, WA)

Genetic Alliance is a non-profit business of more than 600 supporting organizations that assist over 25 million people affected by 1000 health related conditions. The alliance works to transform leadership in the genetics community to facilitate capacity in advocacy organizations and to educate policymakers by leveraging the voices of individuals and families. Genetic Alliance increases the capacity of genetic advocacy organizations to achieve their missions and is dedicated to improving the quality of life for everyone living with genetic conditions.

For more information: http://www.geneticalliance.org/

back to top

Iverson attends “From Prediction to Prevention" The Annual Burrill Personalized Medicine Meeting presented by Burrill Life Sciences Media Group - November 12-13, 2007

November 15, 2007 ( San Francisco , CA)

Iverson Genetic Diagnostics, Inc. attends "From Prediction to Prevention" The 3 rd Burrill & Company is the general partner of the Burrill Life Sciences Capital Fund, L.P. This Fund is the fifth in a series of Burrill venture capital funds and invests exclusively across the entire spectrum of life sciences, including biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, wellness and nutraceuticals, agbio, and industrial biotechnology (biomaterials/bioprocess). The annual Burrill Personalized Medicine meeting is held in San Francisco , CA .

For more information: http://www.burrillandco.com/ back to top
Iverson attends The American Society of Human Genetics 57 th Annual Meeting - October 23-27, 2007 November 1, 2007 ( San Diego , CA)

Iverson Genetic Diagnostics, Inc. attends the 57 th Annual ASHG meeting, held in San Diego , CA . The American Society of Human Genetics (ASHG), founded in 1948, is the primary professional membership organization for human geneticists in the Americas . The nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses and others involved in or with special interest in human genetics.

For more information: http://www.ashg.org/

back to top

Iverson to attend “Eyes on the Prize” Summit hosted by Genetic Alliance Sept 20-21st, 2007

September 17, 2007 (Washington, D.C.)

Iverson Genetic Diagnostics will be attending the “Eyes on the Prize: Truth Telling About Genetic Testing” Summit taking place September 20-21st in Washington , DC . Genetic Alliance is a coalition of more than 600 advocacy organizations serving 25 million people affected by 1000 conditions. The organization works to transform leadership in the genetics community to build capacity in advocacy organizations and to educate policymakers by leveraging the voices of individuals and families. Genetic Alliance increases the capacity of genetic advocacy organizations to achieve their missions and leverages the voices of millions of individuals and families living with genetic conditions.

For more information: http://www.geneticalliance.org/

back to top

Iverson obtains CLIA Certification

August 28, 2007 (Seattle, WA)

Iverson Genetic Diagnostics, Inc. recently gained Clinical Laboratory Improvement Amendment (CLIA) certification from the Office of Laboratory Quality Assurance. Iverson is qualified to practice as a medical testing site for high complexity tests performed on patient specimens.

In accord with the CLIA, the CLIA Program sets standards and issues certificates for clinical laboratory testing. CLIA defines a clinical laboratory as any facility which performs laboratory testing on specimens derived from humans for the purpose of providing information (1) for the diagnosis, prevention, or treatment of disease or impairment, and (2) for the assessment of health. An objective of the CLIA is to ensure the accuracy, reliability and timeliness of test results regardless of where the test was performed.

Centers for Medicare and Medicaid Services (CMS) has the primary responsibility for the operation of the CLIA Program. Within CMS, the program is implemented by the Center for Medicaid and State Operations, Survey and Certification Group, Division of Laboratory Services. The CLIA Program is funded by user fees collected from approximately 189,000 laboratories, most located in the United States .

For more information: http://www.cms.hhs.gov/clia/

back to top

Satterlee and Dubay appointed to Iverson's Board of Directors August 13, 2007 (Seattle, WA)

Dorranne Satterlee is a successful entrepreneur and a member of the Board of Directors for the southeast regional chapter of the American Red Cross. Ms. Satterlee was appointed to Iverson's Board of Directors on July 27, 2007.

Dr. Christopher Dubay is a PhD medical geneticist who applies his informatics skill to develop information management systems supporting research into the understanding of complex genetic systems affecting health and disease. He is an assistant professor at the Oregon Health & Sciences University where he is a passionate teacher, and director of the Genetics Resource & Informatics Program. Mr. Dubay was appointed to Iverson's Board of Directors on August 13, 2007.

back to top

Molecular diagnostics featured on the cover of June 18th, 2007 issue of Forbes Magazine: "Will I Get Cancer?"

June 18, 2007 ( New York , NY )

Forbes Magazine recently devoted a cover story to molecular diagnostics.

Excerpt:

Soon all of us will be able to find out what ticking time bombs lie hidden inside our DNA if we really want to know. This was one of the central promises when scientists decoded the human genome seven years ago--and then a lot of nothing happened. The big obstacle was the high cost of gene decoding; scientists had run through $3 billion mapping the first human genome."

Read the entire article here .

back to top

Biology's Big Bang: Unravelling the secrets of RNA. June 16-22th, 2007 issue of The Economist Magazine devoted to the future of medicine

June 16, 2007 ( London , UK )

The Economist Magazine recently devoted a cover story to the future of medicine.

Excerpt:

NATURE is full of surprises. When atoms were first proved to exist (and that was a mere century ago), they were thought to be made only of electrons and protons. That explained a lot, but it did not quite square with other observations. Then, in 1932, James Chadwick discovered the neutron. Suddenly everything made sense--so much sense that it took only another 13 years to build an atomic bomb.

It is probably no exaggeration to say that biology is now undergoing itsneutron moment." For more than half a century the fundamental story of living things has been a tale of the interplay between genes, in the form of DNA, and proteins, which the genes encode and which do the donkey work of keeping living organisms living. The past couple of years, however, have seen the rise and rise of a third type of molecule, called RNA."

Read the entire article here .

back to top

Iverson Headquarters established at The Institute for Systems Biology Q2 2007

June 1, 2007 (Seattle, WA)

Iverson Genetic Diagnostics, Inc. is pleased to announce the establishment of its worldwide headquarters at the Institute for Systems Biology in Seattle , WA . The Institute for Systems Biology was co-founded in 2000 by Alan Aderem, Ruedi Aebersold, and Leroy Hood. In just five years it has grown to more than 170 staff members, including 11 faculty members and their laboratory groups. This pioneering approach to the study of biological systems takes place in the institute's 65,000-square-foot facility in Seattle .

Building a new kind of research institute -- one that can tackle the multi-disciplinary challenges of systems biology requires a strategy that itself integrates many sciences including biology, chemistry, physics, computation, mathematics and medicine. Because the field of systems biology requires the seamless integration of these disciplines, ISB has developed a philosophy, an environment, and an administrative structure that transcends traditional organizational and disciplinary barriers. Scientists collaborate across their specialties to leverage knowledge and expertise with others at the Institute and in academia and industry.

http://www.systemsbiology.org

back to top